Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.
2.

Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.

Björck F, Sandén P, Renlund H, Svensson PJ, Själander A.

Thromb Res. 2015 Aug;136(2):216-20. doi: 10.1016/j.thromres.2015.04.016. Epub 2015 Apr 22.

PMID:
25935649
3.

Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States.

Baker WL, Cios DA, Sander SD, Coleman CI.

J Manag Care Pharm. 2009 Apr;15(3):244-52.

4.

[The application of thrombin generation tests to warfarin anticoagulation monitoring].

Chen HY, Ding QL, Zhang LW, Xu GQ, Dai J, Wang XF, Xi XD, Wang HL.

Zhonghua Xue Ye Xue Za Zhi. 2008 Mar;29(3):168-70. Chinese.

PMID:
18788615
5.

Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.

Wieloch M, Hillarp A, Strandberg K, Nilsson C, Svensson PJ.

Thromb Res. 2009 Jul;124(3):344-8. doi: 10.1016/j.thromres.2009.03.007. Epub 2009 May 6.

PMID:
19423152
6.
7.

Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care.

Nichol MB, Knight TK, Dow T, Wygant G, Borok G, Hauch O, O'Connor R.

Ann Pharmacother. 2008 Jan;42(1):62-70. Epub 2007 Dec 19.

PMID:
18094348
9.

Home prothrombin time monitoring: a literature analysis.

Yang DT, Robetorye RS, Rodgers GM.

Am J Hematol. 2004 Oct;77(2):177-86. Review.

10.

The impact of patient self-testing of prothrombin time for managing anticoagulation: rationale and design of VA Cooperative Study #481--the Home INR Study (THINRS).

Matchar DB, Jacobson AK, Edson RG, Lavori PW, Ansell JE, Ezekowitz MD, Rickles F, Fiore L, Boardman K, Phibbs C, Fihn SD, Vertrees JE, Dolor R.

J Thromb Thrombolysis. 2005 Jun;19(3):163-72.

PMID:
16082603
13.

Performance of prothrombin-proconvertin time as a monitoring test of oral anticoagulation therapy.

Haraldsson HM, Onundarson PT, Einarsdóttir KA, Guõmundsdóttir BR, Pétursson MK, Pálsson K, Kristinsson A.

Am J Clin Pathol. 1997 Jun;107(6):672-80.

PMID:
9169664
15.

Comparison of two methods for INR determination in a pharmacist-based oral anticoagulation clinic.

Yamreudeewong W, Johnson JV, Cassidy TG, Berg JT.

Pharmacotherapy. 1996 Nov-Dec;16(6):1159-65.

PMID:
8947990
16.

The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.

Deerhake JP, Merz JC, Cooper JV, Eagle KA, Fay WP.

J Thromb Thrombolysis. 2007 Apr;23(2):107-13.

PMID:
17221327
17.

Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial.

Wilson SJ, Wells PS, Kovacs MJ, Lewis GM, Martin J, Burton E, Anderson DR.

CMAJ. 2003 Aug 19;169(4):293-8. Erratum in: CMAJ. 2004 Feb 17;170(4):451.

18.

Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.

Thom J, Ivey L, Gilmore G, Eikelboom JW.

Blood Coagul Fibrinolysis. 2004 Jun;15(4):353-7.

PMID:
15166923
19.

International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.

Oertel LB.

Nurse Pract. 1995 Sep;20(9):15-6, 21-2. Review.

PMID:
7501312
20.

Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.

Agarwal S, Bennett D, Smith DJ.

Am J Cardiovasc Drugs. 2010;10(1):37-48. doi: 10.2165/11318870-000000000-00000.

PMID:
20104933

Supplemental Content

Support Center